AJR 2000; 174:1499-1508
© American Roentgen Ray Society
Nonthrombotic Pulmonary Emboli
Santiago E. Rossi1,2,
Philip C. Goodman1 and
Tomas Franquet3
1
Department of Radiology, Duke University Medical Center, Box 3808, Erwin St.,
Durham, NC 27710.
2
Present address: Department of Radiology, Fundacion Dr. "Enrique
Rossi," Arenales 2777, C P: 1425, Buenos Aires, Argentina.
3
Department of Radiology, Hospital de Sant Pau, Universidad Autonoma de
Barcelona, Sant Antoni M. Claret 167, 08025, Barcelona, Spain.
Received October 4, 1999;
accepted after revision December 13, 1999.
Address correspondence to P. C. Goodman.
Introduction
Thrombotic pulmonary embolism is such a significant and commonly considered
entity that it has, appropriately, been the focus of most articles dealing
with abnormal substances that find their way into pulmonary circulation.
Nevertheless, the spectrum of nonthrombotic pulmonary emboli constitutes an
interesting and clinically relevant topic of discussion. Not all the effects
of the latter are mechanical as is typical with ordinary pulmonary embolism;
therefore, the pathogenesis and presentation of these diseases are
occasionally more complex and subject to continued speculation. We identify
the clinical and radiographic features of nonthrombotic pulmonary emboli.
Septic Embolism
Septic pulmonary emboli are commonly associated with tricuspid valve
endocarditis (e.g., in IV drug users)
[1] but are also detected in
patients with infections from indwelling catheters and pacemaker wires,
peripheral septic thrombophlebitis, and organ transplants
[2]. Typically, patients
present with fever, cough, and hemoptysis.
Chest radiographs reveal peripheral bilateral poorly marginated lung
nodules that have a tendency to form cavities with moderately thick irregular
walls (Figs. 1 and
2). Nodules generally range in
size from 1 to 3 cm and may increase in number or change in appearance (size
or degree of cavitation) from day to day
[3]. Empyemas are frequently
associated with these predominantly staphylococcal infections. CT may be
better than radiography at revealing these lesions because it delineates the
extent of disease and potential complications, such as extension into the
pleural space [1]; however,
chest radiographs are typically adequate for proper patient treatment. On CT,
the most characteristic findings of septic embolism include scatered
predominantly lower lobe discrete parenchymal nodules that show various stages
of cavitation. Nodule-feeding vessels are found in 60-70% of patients
[1,
3]
(Fig. 3), and heterogeneous
subpleural wedge-shaped opacities are identified in 70-75% of patients
[3].

View larger version (86K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3. 56-year-old man with septic embolism and deep venous thrombosis of
lower extremities. Patient presented with dyspnea, fever, and chills. CT scan
(lung window) shows bilateral peripheral cavitary nodules and confirmed
right-sided pleural effusion.
|
|
Typically, diagnosis is suggested by radiographic findings, predisposing
background or illness, and clinical evidence of infection. Antibiotic
treatment is generally successful; however, occasionally the source of emboli
must be surgically repaired.
Catheter Embolism
Catheter emboli, complications of central venous catheterization, were
first described in 1954 [4].
Catheter emboli usually develop when a physician attempts to withdraw a
catheter through an introducing needle. The catheter catches on the needle and
the distal portion is sheared off. The Seldinger technique has reduced the
incidence of this problem. Spontaneous catheter breakage accounts for
approximately 25% of catheter emboli
[5]. Most catheter emboli are
found in the basilic vein and the pulmonary arteries, with the remainder in
the right heart, great veins, and peripheral aspect of the lungs
[4].
Chest radiographs reveal a disconnected catheter fragment overlying an
unexpected portion of the lung, mediastinum, or heart. Generally, the course
of the catheter corresponds to the expected location of the pulmonary artery.
Angiography or CT findings can confirm the position of the catheter (Fig.
4A,4B,4C,4D,4E).

View larger version (132K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4A. 57-year-old woman with catheter embolism and breast cancer. Patient
had part of right subclavian venous line shear off when catheter was being
removed. Posteroanterior chest radiograph shows right subclavian central
venous catheter with tip in superior vena cava.
|
|

View larger version (88K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4B. 57-year-old woman with catheter embolism and breast cancer. Patient
had part of right subclavian venous line shear off when catheter was being
removed. Posteroanterior (B) and lateral (C) chest radiographs
show catheter fragment (arrows) in posterior segment of right upper
lobe.
|
|

View larger version (121K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4C. 57-year-old woman with catheter embolism and breast cancer. Patient
had part of right subclavian venous line shear off when catheter was being
removed. Posteroanterior (B) and lateral (C) chest radiographs
show catheter fragment (arrows) in posterior segment of right upper
lobe.
|
|

View larger version (95K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4D. 57-year-old woman with catheter embolism and breast cancer. Patient
had part of right subclavian venous line shear off when catheter was being
removed. CT scan (mediastinal window) reveals catheter fragment in right
pulmonary artery.
|
|

View larger version (137K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4E. 57-year-old woman with catheter embolism and breast cancer. Patient
had part of right subclavian venous line shear off when catheter was being
removed. Pulmonary angiogram shows catheter fragment in right upper lobe
pulmonary artery. Catheter was removed using 35-mm snare device.
|
|
Treatment with intravascular retrieval using snares is frequently
successful.
Fat Embolism Syndrome
The first clinical description of fat embolism syndrome appeared in 1873
[6,
7]. This embolism is an
uncommon complication of longbone fractures, occurring in 1-20% of trauma
patients
[6,7,8].
A small number of patients without skeletal trauma have also presented with
fat embolism syndrome; the etiology of disease in these patients includes
hemoglobinopathy, severe burns, soft-tissue injuries, diabetes, pancreatitis,
severe infection, neoplasms, osteomyelitis, blood transfusion, cardiopulmonary
bypass, altitude decompression, suction lipectomy, and renal transplantation
[6,
7].
The pathogenesis of fat embolism syndrome is not completely understood. One
theory proposes that neutral triglycerides are transported to the lung and
converted to free fatty acids that instigate a toxic reaction in the capillary
endothelium [7,
9]. This injury is compounded
by the accumulation of inflammatory cells, particularly neutrophils, that
cause further damage to the vasculature. Fat emboli also obstruct vessels, but
this mechanical effect is thought to be less important in the lungs
[9]. Fat emboli circulating
through a patent foramen ovale, atrial septal defect, or intapulmonary shunt
bypass the lungs and appear in the microvasculature of the brain and other
organs, in which vascular obstruction may be more critical.
Clinically, fat embolism syndrome appears as a combination of pulmonary,
cerebral, and cutaneous symptoms that may occur immediately or may develop up
to 3 days after trauma [6,
10]. This delay is probably
related to continuous embolization from the fracture site and the time
required to convert fat globules into free fatty acids. Pulmonary
manifestations include dyspnea, tachypnea, hyperpnea, and hemoptysis. Patients
also present with tachycardia, chest pain, cyanosis, and fever
[6,
7,
9,
10]. Neurologic symptoms occur
in up to 85% of patients and include confusion, restlessness, stupor, and
coma. Neurologic abnormalities may be the first indication of fat embolism;
however, they are generally reversible
[9]. Dermatologic features
occur in 20-50% of patients and include petechiae of the skin and mucous
membranes, particularly in the anterior thorax, anterior axillary folds, head,
and neck [7]. Skin findings
coincide with the onset of neurologic symptoms and generally resolve in 5-7
days [6]. The anterior
distribution of petechiae is probably caused by the differential streaming of
fat globules to the upper aorta and its more ventral branches
[7].
Chest radiographic abnormalities usually appear 1-2 days after trauma and
resolve within 1 week. Typically, patients with fat embolism syndrome develop
bilateral homogeneous and heterogeneous opacities that resemble those of
pulmonary edema or acute respiratory distress syndrome
[6,
9] (Fig.
5A,5B,5C).
Differentiation from cardiogenic edema can be determined by identifying a
normal heart size and lack of vascular redistribution. Pleural effusions are
uncommon. Fat embolism syndrome should be considered when patients have
suggestive chest radiographic findings, a history of trauma 1-3 days before
their present complaints, and appropriate physical signs and symptoms;
however, fat in the conjunctivae and retinal infarcts may be suggestive of fat
embolism syndrome. Fat in the urine, serum, or sputum does not have a high
enough specificity or sensitivity on which to base the diagnosis of fat
embolism syndrome [6].

View larger version (54K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5A. 34-year-old man with fat embolism and many injuries from motor
vehicle collision. Patient experienced new respiratory problems 72 hr later.
Anteroposterior radiograph of right femur reveals transverse fracture.
|
|

View larger version (121K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5B. 34-year-old man with fat embolism and many injuries from motor
vehicle collision. Patient experienced new respiratory problems 72 hr later.
Anteroposterior chest radiographs obtained 24 (B) and 72 hr (C)
after A show increase in diffuse heterogeneous opacities in both lungs,
consistent with edema caused by fat embolism.
|
|

View larger version (124K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5C. 34-year-old man with fat embolism and many injuries from motor
vehicle collision. Patient experienced new respiratory problems 72 hr later.
Anteroposterior chest radiographs obtained 24 (B) and 72 hr (C)
after A show increase in diffuse heterogeneous opacities in both lungs,
consistent with edema caused by fat embolism.
|
|
Supportive therapy usually results in recovery. Early surgical correction
of fractures may reduce the incidence of fat embolism syndrome by decreasing
tissue pressure and halting fat globule release
[6].
Venous Air Embolism
Venous air embolism is a well-known complication of thoracic trauma,
surgery, and a variety of diagnostic and therapeutic procedures
[11]. These emboli have been
reported after transthoracic needle aspiration and biopsy, penetrating
injuries to the lung, barotrauma caused by positive pressure ventilation, and
hemodialysis; and in patients with asthma, neonates with respiratory distress,
and scuba divers [12,
13]. Small amounts of air can
be identified in the larger systemic intrathoracic veins in 23% of patients
undergoing IV injection of contrast material for CT and in 1/47-1/3000
patients after the insertion of subclavian or central venous catheters
[14]
(Fig. 6). The amount and speed
of air introduction, body position, and general clinical health influence the
risk of death from venous air embolism
[15]. In humans, the lethal
volume of air is usually between 300 and 500 ml injected at a rate of 100
ml/sec [14]. Large volumes of
rapidly infused air are most likely to cause major hemodynamic compromise
[14]; however, injections of
air in amounts as small as 100 ml have caused death
[16]. The major effect of
venous air embolism is the obstruction of the right ventricular pulmonary
outflow tract or obstruction of the pulmonary arterioles by a mixture of air
bubbles and fibrin clots formed in the heart. The result in either situation
is cardiovascular dysfunction and failure
[14]. Interstitial and
alveolar edema (caused by high regional pressures) may also occur in
unobstructed areas of the pulmonary circulation.

View larger version (69K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6. 40-year-old asymptomatic man with incidental air embolism. CT scan
(mediastinal window) shows air in left brachiocephalic vein (arrow)
after IV contrast injection for contrast-enhanced chest CT.
|
|
The clinical manifestations of venous air embolism are variable and
nonspecific. Typically, patients experience the sudden onset of air hunger,
dyspnea, cough, dizziness, chest pain, and a feeling of impending death
[6,
11,
14]. Tachycardia, tachypnea,
and hypotension are frequently discovered on physical examination, and
occasionally, a relatively specific drumlike or "mill wheel" heart
murmur is heard [6,
11,
14,
17]. A gasp reflex consisting
of a short cough followed by brief expiration and several seconds of forced
inspiration may be observed after IV infusion of air. Neurologic symptoms such
as altered mental status, convulsions, and coma occur in 42% of patients
[14]. Additional symptoms
include increased central venous or pulmonary artery pressure, signs of
ischemia or cor pulmonale on electrocardiography, and decreased end tidal
CO2 fraction
[11].
Chest radiographic findings of venous air embolism include normal findings;
radiolucency (air) in the main pulmonary artery, heart
(Fig. 7), and hepatic veins;
focal pulmonary oligemia; pulmonary edema; enlarged central pulmonary
arteries; dilatation of the superior vena cava; and subsegmental atelectasis
[11]. Air in the distal main
pulmonary artery may appear in a characteristic bell shape
[11]
(Fig. 8). Air in the more
distal pulmonary vessels is rarely detected on chest radiographs. Chest CT may
reveal small amounts of air in the axillary, subclavian, internal jugular, or
brachiocephalic veins; superior vena cava; right heart; or main pulmonary
arteries [18]. Diminished
pulmonary vascularity or focal oligemia may be more frequent in the upper
lobes.

View larger version (160K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 7. 48-year-old man with air embolism and trauma to right chest, causing
communication between large bronchus and adjacent pulmonary vein.
Posteroanterior chest radiograph reveals radiolucency representing air in
heart. Patient died soon after scanning.
|
|

View larger version (132K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 8. 32-year-old man with air embolism that disconnected patient's
central venous line. Anteroposterior chest radiograph shows bell- or
coned-shaped radiolucency (arrow) in main pulmonary artery.
Hyperlucent upper lobes result from oligemia caused by obstruction of
pulmonary artery by air emboli. (Reprinted with permission from
[11])
|
|
The diagnosis of venous air embolism is generally suspected when an
appropriate clinical situation is coupled with consistent physical examination
features and typical radiographic findings.
The treatment of venous air embolism is initially directed at restoring
cardiopulmonary circulation and promoting reabsorption of intravascular air.
Patients with suspected venous air embolism should be placed in a left lateral
decubitus head-down position because it causes right-sided cardiac air bubbles
to rise to the periphery of the right atrium and out of the blood flow through
the right heart. Occasionally, intraoperative needle aspiration is performed
to relieve large air bubbles. Oxygen should be administered because it creates
a favorable environment for decreasing the partial pressure of nitrogen in the
air bubbles, thus reducing their size.
Amniotic Fluid Embolism
Amniotic fluid emboli were first described in 1926. In 1954, after the
autopsy descriptions of eight women who had amniotic fluid debris (e.g.,
squamous cells and mucin) in their pulmonary arteries were published, amniotic
fluid embolism became widely recognized as a cause of postpartum death
[6,
19]. Amniotic emboli are a
rare phenomenon, occurring in 1/8000-1/80,000 pregnancies; however, the emboli
result in high maternal and fetal mortality rates, 80% and 40%, respectively
[19,20,21].
Amniotic fluid embolism ranks third in incidence of non-abortion-related
maternal mortality during labor (after pulmonary embolism and hypertension)
[22]. Risk factors associated
with the development of amniotic fluid emboli include advanced maternal age,
multiparity, prolonged gestation, intrauterine demise, use of uterine
stimulants, large fetal size, premature rupture of membranes, and meconium
staining of the amniotic fluid
[23]. Furthermore, amniotic
fluid emboli have been associated with first-trimester curettage abortion
[6]; second-trimester abortions
by hysterotomy or prostaglandin, saline and urea injections
[6,
24]; blunt abdominal trauma
[24]; amniocentesis;
hysterectomy; and cesarean delivery
[6]. Most amniotic fluid emboli
develop during the first stage of labor
[25], but delayed symptoms can
occur up to 48 hr after delivery
[19]. Uterine contractions
during normal labor force amniotic fluid into the maternal venous circulation
through small tears in the lower uterine segment or high endocervical canal
[23]. Aside from normal labor,
some amniotic fluid emboli occur during surgical or traumatic events that
disrupt the placenta [23,
26].
The pathophysiology of amniotic fluid emboli remains unclear. Two main
theories have been postulated
[21]. The conventional
explanation states that particulate matter such as fetal squamous cells,
lanugo, and meconium contained in the amniotic fluid produce pulmonary
vascular obstructions that lead to pulmonary hypertension, right- and
left-sided heart failure, hypotension, and death
[21,
24]. However, current evidence
suggests that a mechanical origin is less likely than an immunologic reaction
[19,
24]. In this model, pulmonary
vasospasm causes a physiologic pulmonary artery obstruction as a reaction to
abnormal substances (e.g., leukotrienes and metabolites of arachnoid acid such
as prostaglandins) in the amniotic fluid
[19]. Subsequent severe
pulmonary hypertension and marked hypoxia result in the death of 50% of
patients within the first hour
[21,
24,
25]. Most deaths occur within
the first 2 hr of the onset of symptoms
[25]. Survivors display a mild
to moderate increase in mean pulmonary arterial pressure, a variable increase
in central venous pressure, and a high pulmonary capillary wedge pressure
caused by acute left-sided ventricular failure
[21].
The classic clinical presentation of amniotic fluid embolism is that of
abrupt dyspnea, cyanosis, and shock, followed (within minutes) by
cardiorespiratory arrest and severe pulmonary edema, which occur in 70% of
patients [19,
23,
24]. Some patients present
with an anaphylactic reaction caused by a hypersensitivity to the leukotrienes
and arachnoid metabolites present in amniotic fluid
[26]. Central nervous system
irritability that produces convulsions is typical. Additionally, 40% of
patients suffer a consumptive coagulopathy (e.g., disseminated intravascular
coagulation) [21]. This latter
effect may be explained by the role of amniotic fluid in initiating fibrinogen
consumption and in releasing tissue activators of the fibrinolytic system
[21,
24]. Excessive bleeding caused
by the consumptive coagulopathy may complicate the clinical situation but can
usually be treated successfully.
In patients who live long enough to undergo chest radiography, pulmonary
edema or acute respiratory distress syndrome is most commonly revealed
[6]
(Fig. 9). Chest radiographs
reveal diffuse bilateral heterogeneous and homogeneous opacities.

View larger version (112K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 9. 33-year-old woman with amniotic fluid embolism. Patient was not
responsive to induction of labor and proceeded to cesarean delivery. While
uterus was being sutured, patient had tonic-clonic seizure followed by cardiac
arrest. Supportive measures were instituted, but patient died 3 weeks later.
Anteroposterior chest radiograph obtained shortly after cesarean delivery
reveals mild cardiomegaly and bilateral lung opacities that are denser on left
side. Findings were attributed to asymmetric pulmonary edema caused by
presumed amniotic fluid embolism.
|
|
The clinical diagnosis of amniotic fluid embolism relies heavily on the
patient's risk factors and presentation. At autopsy, fetal squamous cells,
mucin, hair, and meconium are revealed in the pulmonary vasculature
[21,
23].
Treatment is supportive, including maintenance of oxygenation, cardiac
output, and blood pressure. Bleeding from disseminated intravascular
coagulopathy is usually self-limited but can be treated with transfusions
[6,
19,
21].
Tumor Embolism
Embolism of tumor cells from a distant primary neoplasm to the pulmonary
vasculature was first described in 1897
[6,
27]. The incidence of tumor
emboli is difficult to establish, but autopsy series reveal a range between
2.4% and 26% of patients [28].
Common sources of tumor emboli include liver, breast, stomach, renal, and
prostatic cancers and choriocarcinoma
[27,
28]. Pulmonary involvement
includes occlusion of the main pulmonary artery by a large amount of tumor
material, microscopic arteriolar emboli, diffuse alveolar septal capillary
involvement, lymphangitic carcinomatosis, or a combination of these entities
[6,
27,
29].
Clinically, the most common symptom of patients with tumor emboli is
dyspnea that slowly develops over days or weeks (reported in as many as 70% of
patients) [6,
27]. Pleuritic chest pain
[6,
29], cough
[6], hemoptysis
[6,
27,
29], fatigue, and weight loss
[27] are also seen. Physical
examination typically reveals signs of pulmonary hypertension and right-sided
ventricular overload [6,
27,
29].
Chest radiographs usually reveal normal findings, but occasional, focal or
diffuse heterogeneous opacities are observed, which may be interpreted as
lymphangitic carcinomatosis, especially in patients with known cancer
[6,
27]. Cardiac enlargement and
prominent pulmonary arteries are infrequent findings despite the elevation of
pulmonary artery pressure
[27]. CT may reveal dilated
and beaded peripheral pulmonary arteries. Additionally, bilateral peripheral
wedge-shaped opacities, suggestive of pulmonary infarcts, have also been
reported [30,
31]
(Fig. 10). Radionuclide
perfusion scans may reveal small peripheral subsegmental mottled perfusion
defects, whereas ventilation scans are usually normal
[32] (Fig.
11A,11B).
Pulmonary angiography is usually unrevealing but may show the delayed filling
of the segmental arteries, pruning and tortuosity of the third- to fifth-order
vessels, and occasional subsegmental filling
[6,
33].

View larger version (97K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 10. 48-year-old woman with tumor embolism and history of stage IIIB
carcinoma of uterine cervix. Patient presented with increasing dyspnea on
exertion, cough, and occasional hemoptysis. CT scan (lung window) shows
bilateral peripheral pulmonary opacities, some wedge-shaped, suggesting
pulmonary infarcts. Autopsy confirmed multiple tumor emboli in pulmonary
circulation. (Courtesy of Haramati LB, Bronx, NY)
|
|

View larger version (143K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 11A. 70-year-old woman with tumor embolism and adenocarcinoma of unknown
primary source. Patient presented with acute dyspnea and shortness of breath.
Anteroposterior chest radiograph shows mild cardiomegaly and normal lungs.
|
|

View larger version (116K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 11B. 70-year-old woman with tumor embolism and adenocarcinoma of unknown
primary source. Patient presented with acute dyspnea and shortness of breath.
99mTc macroaggregated albumin radionuclide perfusion scan reveals
numerous peripheral wedge-shaped perfusion defects, characteristic of tumor
emboli. Autopsy confirmed tumor emboli in pulmonary circulation. LPO = left
posterior oblique, POST = posterior, RPO = right posterior oblique, RAO =
right anterior oblique, ANT = anterior, LAO = left anterior oblique.
|
|
Diagnosis is usually made at autopsy; however, tumor embolism is
occasionally confirmed with positive cytology findings in aspirated pulmonary
arteriolar blood [6].
Talc Embolism
Many substances, such as magnesium trisilicate (talc), starch, and
cellulose, are used as fillers in drug manufacturing
[34]. Some of these drugs
(prepared as oral medications) such as amphetamines, methylphenidate,
hydromorphone, and dextropropoxyphene are ground by drug users, mixed in
liquid, and injected IV [35].
In this way, talc particles reach small pulmonary arterioles and capillaries
where a foreign body giant cell granulomatous reaction occurs. Confluence of
the granulomas and subsequent fibrosis and distortion of lung architecture,
especially in the upper lobes, may follow. Pulmonary hypertension may develop
as a result of chronic lung changes
[36].
Most patients with talc emboli are asymptomatic; however, dyspnea and
persistent cough occur with severe talc exposure. Clinical features appear to
be dose-related and may progress even after stopping drug injections
[36].
Initially, chest radiographs reveal several small (1 mm in diameter)
nodular and reticular opacities throughout the lungs
[36] (Fig.
12A,12B).
Later, homogeneous upper lobe opacities resembling progressive massive
fibrosis may be identified. Large pulmonary arteries and a large right heart
may be observed in patients with pulmonary hypertension
[37]. Lymphadenopathy is
rare.

View larger version (120K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 12A. 26-year-old female drug user with talc embolism. Patient had
injected dissolved methylphenidate hydrochloride tablets IV and presented with
long-standing pulmonary hypertension. Posteroanterior chest radiograph shows
fine reticular opacities in lower lobes and large central pulmonary
arteries.
|
|

View larger version (149K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 12B. 26-year-old female drug user with talc embolism. Patient had
injected dissolved methylphenidate hydrochloride tablets IV and presented with
long-standing pulmonary hypertension. Coned-down radiograph of left lower lobe
shows fine reticular pattern.
|
|
Mercury Embolism
Pulmonary emboli caused by the accidental or intentional IV injection of
metallic mercury is rare [38].
Clinical manifestations include dyspnea, cough, and mild hypoxia, which
develop shortly after injection
[39]. Pulmonary function
testing may show restricted ventilation and reduced diffusing capacity
[39]. Mercury levels in the
blood and urine are usually elevated, but there is no correlation between
mercury levels and signs and symptoms of intoxication
[38,
40]. Renal damage can also
occur, but the resulting proteinuria and pyuria are transient
[40].
Chest radiographic findings are striking and should immediately suggest the
diagnosis of mercury emboli. Multiple small metallic spherules diffusely
distributed throughout the lungs, or occasionally restricted to one or more
dependent areas, are most common
[38]. The opacities may be
scattered, may be of different size, or may appear as beaded chains following
the course of the pulmonary arteries, simulating the appearance of an
angiogram [38,
41]
(Fig. 13A). Metallic mercury
may also be identified in the heart and coronary arteries
[38]. Abnormal findings on
chest radiographs may gradually resolve or may remain permanently
[38]. Aspiration of metallic
mercury is the main condition requiring differentiation from mercury embolism
[38,
40,
41]. Aspirated mercury
produces predominately lower lobe linear rather than nodular opacities
[42]. Radionuclide
ventilation-perfusion scans with 99mTc-labelled macroaggregate
albumin and 81Kr can differentiate aspirated intrabronchial mercury
from pulmonary artery mercury emboli
[40]. If intracardiac,
abdominal vessel, or extremity subcutaneous tissue mercury is observed, then
mercury embolization, not aspiration, is responsible
(Fig. 13B).

View larger version (109K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 13A. 31-year-old man with mercury embolism. Patient injected mercury IV.
Posteroanterior chest radiograph shows multiple fine round metallic opacities
in both lungs. In medial right lung, round opacities line up in direction of
right lower lobe pulmonary artery.
|
|

View larger version (127K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 13B. 31-year-old man with mercury embolism. Patient injected mercury IV.
Anteroposterior abdominal radiograph with patient supine shows multiple
metallic opacities in liver, kidneys, ureters, and bladder.
|
|
The prognosis for patients with mercury emboli is good. After several
weeks, symptoms and functional impairments will diminish
[39].
Iodinated Oil Embolism
Iodinated oily emboli are almost always caused by lymphangiography
performed in patients with lymphatic obstruction
[43]. In one study, 44 of 80
such patients developed this complication
[44]. Occlusion of the flow of
lymph presumedly causes contrast material to enter systemic veins. Ultimately,
the contrast material enters the pulmonary circulation, where lipid and oil
droplets are widely distributed
[45]. Clearance of contrast
material into the interstitial and occasionally the alveolar spaces occurs
over several days.
Although fever may develop within 2 days of lymphangiography, most patients
with iodinated contrast emboli are asymptomatic. Rarely, cough, dyspnea, and
hypotension occur.
Chest radiographs reveal subtle fine nodular opacities immediately after
lymphangiography (Fig. 14). As
resolution occurs, the pattern becomes more reticular and may last for several
weeks [43,
44].

View larger version (139K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 14. 53-year-old man with iodinated contrast embolism. After
lymphangiography, patient complained of shortness of breath. Coned-down
radiograph of left upper lobe shows fine diffuse reticulonodular opacities.
Contrast material is also present in left supraclavicular lymph nodes.
|
|
Cotton Embolism
Cotton emboli were first described in 1949
[46]. Cotton emboli occur when
IV drug users inject narcotics through cotton swabs and fibers enter systemic
venous circulation. Additionally, these emboli can occur when cotton fibers
remain on angiographic guidewires or catheters after they have been wiped with
moist cotton gauze [46]. In
experimental animal studies, cotton fibers incite a granulomatous reaction in
the wall of the pulmonary artery. This reaction occludes the artery and causes
a disruption of the vessel wall, with passage of the cotton fibers into the
alveoli and pulmonary interstitium
[47].
Chest radiographs usually show normal findings, but inflammatory reaction,
granulomatous changes, or both may produce poorly marginated homogeneous
opacities in both lungs (Fig.
15).

View larger version (135K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 15. 22-year-old female IV drug user with cotton embolism and shortness
of breath. Patient typically used cotton balls to clean her skin and inserted
needle through cotton while injecting narcotics. Posteroanterior chest
radiograph reveals multiple poorly marginated hazy and homogeneous opacities
in both lungs. Open lung biopsy results revealed chronic inflammatory reaction
and refractile cotton fibers.
|
|
Hydatid Embolism
Hydatid disease is a tapeworm parasitosis caused by the larval stage of
Echinococcus granulosus
[48]. In the United States,
fewer than 100 cases are identified annually. Although these lesions are
reported in almost all organs, the liver and lungs are most commonly involved
[49]. Hydatid pulmonary emboli
are caused by the direct passage of hydatid material (vesicles, daughter
cysts, scolises) through pulmonary vessels. Hydatid pulmonary emboli have
three clinical presentations: massive embolization followed by sudden death,
pulmonary hypertension followed by death within 1 year, or a protracted course
of pulmonary hypertension
[48].
Clinical manifestations include chest pain, cough, exertional dyspnea,
hemoptysis, and rare anaphylactic reactions.
Chest radiographs are usually not helpful because they do not reveal
intravascular parasites; however, radiographic findings may suggest the
diagnosis of pulmonary infection by showing lung parenchymal hydatid cysts
[50]. CT findings include
pulmonary artery enlargement resulting from intravascular hydatid material
(Fig.
16A,16B).
Pulmonary angiography reveals segmental or lobar perfusion defects caused by
occlusion of the large pulmonary arteries
[48].

View larger version (84K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 16A. 22-year-old woman with hydatid embolism and history of pulmonary
hydatid disease. Patient presented with 6-month history of dyspnea on exertion
and hemoptysis. Contrast-enhanced CT scan (mediastinal window) reveals
hypodense material in lower lobe pulmonary arteries. (Reprinted with
permission from [48])
|
|

View larger version (106K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 16B. 22-year-old woman with hydatid embolism and history of pulmonary
hydatid disease. Patient presented with 6-month history of dyspnea on exertion
and hemoptysis. Contrast-enhanced CT scan (lung window) reveals marked
dilatation of pulmonary arteries resulting from intravascular embolized
material.
|
|
Serum immunoelectrophoresis is the most reliable laboratory test for
hydatidosis. The prognosis of patients with hydatid embolism is poor, and lung
transplantation is the treatment of choice in selected cases
[48].
Conclusion
Nonthrombotic pulmonary emboli can be caused by a wide range of substances.
Radiologic diagnosis is important because clinical findings are often
nonspecific. Although many radiologic manifestations exist, findings are often
characteristic and enable a confident diagnosis. Knowledge of nonthrombotic
pulmonary emboli and awareness of their radiologic findings is essential in
suggesting the correct diagnosis and hastening appropriate treatment.
References
-
Kuhlman JE, Fishman EK, Teigen C. Pulmonary septic emboli:
diagnosis with CT. Radiology
1990;174:211
-213[Abstract/Free Full Text]
-
Bach MC, Roediger JH, Rinder HM. Septic anaerobic jugular phlebitis
with pulmonary embolism: problems in management. Rev Infect
Dis 1988;10:424
-427[Medline]
-
Huang RM, Naidich DP, Lubat E, Schinella R, Garay SM, McCauley DI.
Septic pulmonary emboli: CT-radiographic correlation.
AJR
1989;153:41
-45[Abstract/Free Full Text]
-
Propp DA, Cline D, Hennefent BR. Catheter embolism. J
Emerg Med 1988;6:17
-21[Medline]
-
Blair E, Hanziker R, Flanagan ME. Catheter embolism.
Surgery
1970;67:457
-461[Medline]
-
King MB, Harmon KR. Unusual forms of pulmonary embolism.
Clin Chest Med
1994;15:561
-580[Medline]
-
Richards RR. Fat embolism syndrome. Can J
Surg 1997;40:334
-339[Medline]
-
Hager CA, Brncick N. Fat embolism syndrome: a complication of
orthopedic trauma. Orthop Nurs
1998;17:41
-43
-
Feldman F, Ellis K, Green WM. The fat embolism syndrome.
Radiology
1975;114:535
-542[Abstract]
-
Johnson MJ, Lucas GL. Fat embolism syndrome.
Orthopedics
1996;19:41
-48[Medline]
-
Kizer KW, Goodman PC. Radiographic manifestations of venous air
embolism. Radiology
1982;144:35
-39[Free Full Text]
-
Cholankeril JV, Joshi MD, Cenizal JS, Ketyer S, O'Connor WT.
Massive air embolism from the pulmonary artery.
Radiology
1982;142:33
-34[Free Full Text]
-
Gallagher TJ. Scuba diving accidents: decompression sickness, air
embolism. J Fla Med Assoc
1997;84:446
-451
-
Orebaugh SL. Venous air embolism: clinical and experimental
considerations. Crit Care Med
1992;20:1169
-1177[Medline]
-
Groell R, Schaffler G, Reinhenmueller R, Kern R. Vascular air
embolism: location, frequency and cause on electron beam CT studies of the
chest. Radiology
1997;202:459
-462[Abstract/Free Full Text]
-
Price DB, Nardi P, Teitcher J. Venous air embolization as a
complication of pressure injection of contrast media: CT findings.
J Comput Assist Tomogr
1987;11:294
-295[Medline]
-
Mendieta JM, Roy TM, Denny DM. Venous air embolism with removal of
central venous catheters. J Ky Med Assoc
1998;86:169
-173
-
Woodring JH, Freid AM. Nonfatal venous air embolism after
contrast-enhanced CT. Radiology
1988;167:405
-407[Abstract/Free Full Text]
-
Clark SL. New concepts of amniotic fluid embolism: a review.
Obstet Gynecol Surv
1990;45:360
-368[Medline]
-
Hankins GDV, Snyder RR, Clark SL, Schwartz L, Patterson WR, Butzin
CA. Acute hemodynamic and respiratory effects of amniotic fluid embolism in
the pregnant goat model. Am J Obstet Gynecol
1993;168:1113
-1130[Medline]
-
Chantelian SM, Quirk JG. Amniotic and thromboembolism.
Clin Obstet Gynecol
1990;33:473
-481[Medline]
-
Dorfman SF. Maternal mortality in New York City, 1981-1983.
Obstet Gynecol
1990;76:317
-323[Medline]
-
Burrows A, Khoo SK. The amniotic fluid embolism syndrome: 10 years'
experience at a major teaching hospital. Aust N Z J Obstet
Gynaecol 1995;35:245
-250[Medline]
-
Lau G. Amniotic fluid embolism as a cause of sudden maternal death.
Med Sci Law
1994;34:213
-220[Medline]
-
Clark SL, Hankins GDV, Duddley D, Didly G, Porter T. Amniotic fluid
embolism: analysis of the national registry. Am J Obstet
Gynecol 1995;172:1158
-1169[Medline]
-
Azegami M, Mori N. Amniotic fluid embolism and leukotrienes.
Am J Obstet Gynecol
1986;155:1119
-1124[Medline]
-
Chan CK, Hutcheon MA, Hyland RH, Smith GJ, Patterson BJ, Matthay
RA. Pulmonary tumor embolism: a critical review of clinical, imaging and
hemodynamic features. J Thorac Imaging
1987;2:4
-14[Medline]
-
Veinot J, Ford S, Price R. Subacute cor pulmonale due to tumor
embolization. Arch Pathol Lab Med
1992;116:131
-134[Medline]
-
Soares FA, Magnani Landell A, Mello de Oliveira JA. Clinical
aspects of tumor involvement of the pulmonary vessels. Acta
Oncol 1992;31:519
-523[Medline]
-
Shepard JO, Moore EH, Templeton PA, McLoud TC. Pulmonary
intravascular tumor emboli: dilated and beaded peripheral pulmonary arteries
at CT. Radiology
1993;187:797
-801[Abstract/Free Full Text]
-
Kim AE, Haramati LB, Janus D, Borczuk A. Pulmonary tumor embolism
presenting as infarcts on computed tomography. J Thorac
Imaging 1999;14:135
-137[Medline]
-
Crane R, Rudd TG, Dail D. Tumor microembolism: pulmonary perfusion
pattern. J Nucl Med
1995;332:877
-880
-
Chakeres DW, Spiegel PK. Fatal pulmonary hypertension secondary to
intravascular metastatic tumor emboli. AJR
1982;139:997
-1000[Free Full Text]
-
Marschke GM, Haber LH, Freiberg M. Pulmonary talc embolization.
Chest
1975;68:824
-826[Abstract/Free Full Text]
-
Hill AD, Toner ME, Fitagerald MX. Talc in a drug abuser.
Ir J Med Sci
1990;159:147
-148[Medline]
-
Saadjian A, Gueunoun M, Philip-Joet F, et al. Pulmonary
hypertension secondary to talc microemboli in a HIV seropositive heroin-addict
woman. Arch Mal Coeur Vaiss
1991;84:1369
-1373[Medline]
-
Stern WZ, Subbarao K. Pulmonary complications of drug addiction.
Semin Roentgenol
1983;18:183
-197[Medline]
-
Peterson N, Warwick HS, Rohrmann CA. Radiologic aspects of metallic
mercury embolism. AJR
1980;135:1079
-1081[Medline]
-
Schaffer BA, Schmidt-Nowara WW. Multiple small opacities of
metallic density in the lung. Chest
1989;96:1179
-1181[Free Full Text]
-
Oliver RM, Thomas MR, Cornaby AJ, Neville E. Mercury pulmonary
emboli following intravenous self-injection. Br J Dis
Chest 1987;81:76
-79[Medline]
-
Vas W, Tuttle RJ, Zylak CJ. Intravenous self-administration of
metallic mercury. Radiology
1980;137:313
-315[Abstract/Free Full Text]
-
Janus C, Klein B. Aspiration of metallic mercury: clinical
significance. Br J Radiol
1982;55:675
-676[Abstract/Free Full Text]
-
Francis RA, Barnes PA, Libshitz HI. Pulmonary oil embolism after
lymphography. J Comput Assist Tomogr
1983;7:170
-171
-
Bron KM, Baum S, Abrams HL. Oil embolism in lymphangiography:
incidence, manifestation and mechanism. Radiology
1963;80:194
-202
-
Knochel JQ, Koehler PR, Miller FJ. Need for chest radiographs
during and after lymphography. AJR
1979;132:981
-982[Abstract]
-
Adams DF, Olin TB, Kosek J. Cotton fibre embolism during
angiography. Radiology
1965;84:678
-681
-
Johnston B, Smith P, Health D. Experimental cotton fibre pulmonary
embolism in the rat. Thorax
1981;36:910
-916[Abstract/Free Full Text]
-
Franquet T, Plaza V, Llauger J, Gimenez A, Bordes R. Hydatid
pulmonary embolism from a ruptured mediastinal cyst: high resolution computed
tomography, angiography and pathologic features. J Thorac
Imaging 1999;14:138
-141[Medline]
-
Balikian JP, Mudarris FF. Hydatid disease of the lungs: a
roentgenologic study of 50 cases. AJR
1974;122:692
-707[Abstract]
-
Hirzalla MO, Samara N, Ateyat B, et al. Recurrent hydatid pulmonary
embolism. Am Rev Respir Dis
1989;140:1082
-1085[Medline]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. G. Jorens, E. Van Marck, A. Snoeckx, and P. M. Parizel
Nonthrombotic pulmonary embolism
Eur. Respir. J.,
August 1, 2009;
34(2):
452 - 474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Authors/Task Force Members, A. Torbicki, A. Perrier, S. Konstantinides, G. Agnelli, N. Galie, P. Pruszczyk, F. Bengel, A. J.B. Brady, D. Ferreira, et al.
Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)
Eur. Heart J.,
September 2, 2008;
29(18):
2276 - 2315.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Martinez, L. E. Heyneman, H. P. McAdams, S. E. Rossi, C. S. Restrepo, and A. Eraso
Mucoid Impactions: Finger-in-Glove Sign and Other CT and Radiographic Features1
RadioGraphics,
September 1, 2008;
28(5):
1369 - 1382.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Dodd, C. A. Souza, and N. L. Muller
High-resolution MDCT of pulmonary septic embolism: evaluation of the feeding vessel sign.
Am. J. Roentgenol.,
September 1, 2006;
187(3):
623 - 629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Cook, R. W. Ashton, G. L. Aughenbaugh, and J. H. Ryu
Septic Pulmonary Embolism: Presenting Features and Clinical Course of 14 Patients
Chest,
July 1, 2005;
128(1):
162 - 166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Rossi, T. Franquet, M. Volpacchio, A. Gimenez, and G. Aguilar
Tree-in-Bud Pattern at Thin-Section CT of the Lungs: Radiologic-Pathologic Overview
RadioGraphics,
May 1, 2005;
25(3):
789 - 801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Parambil, C. D. Savci, H. D. Tazelaar, and J. H. Ryu
Causes and Presenting Features of Pulmonary Infarctions in 43 Cases Identified by Surgical Lung Biopsy
Chest,
April 1, 2005;
127(4):
1178 - 1183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. George, H. D. Tazelaar, S. J. Swensen, and J. H. Ryu
Clinicoradiological Features of Pulmonary Infarctions Mimicking Lung Cancer
Mayo Clin. Proc.,
July 1, 2004;
79(7):
895 - 898.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Cook, T. A. Orszulak, V. T. Nkomo, J. A. Shuford, W. D. Edwards, and J. H. Ryu
Aspergillus Infection of Implantable Cardioverter-Defibrillator
Mayo Clin. Proc.,
April 1, 2004;
79(4):
549 - 552.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Han, K. S. Lee, T. Franquet, N. L. Muller, T. S. Kim, H. Kim, O J. Kwon, and H. S. Byun
Thrombotic and Nonthrombotic Pulmonary Arterial Embolism: Spectrum of Imaging Findings
RadioGraphics,
November 1, 2003;
23(6):
1521 - 1539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Ryu and S. J. Swensen
Cystic and Cavitary Lung Diseases: Focal and Diffuse
Mayo Clin. Proc.,
June 1, 2003;
78(6):
744 - 752.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Hansell
Small-Vessel Diseases of the Lung: CT-Pathologic Correlates
Radiology,
December 1, 2002;
225(3):
639 - 653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K S Wong, T Y Lin, Y C Huang, S H Hsia, P H Yang, and S M Chu
Clinical and radiographic spectrum of septic pulmonary embolism
Arch. Dis. Child.,
October 1, 2002;
87(4):
312 - 315.
[Abstract]
[Full Text]
[PDF]
|
 |
|